|Bid||82.61 x 900|
|Ask||85.99 x 800|
|Day's range||82.92 - 85.05|
|52-week range||51.51 - 92.08|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||64.59|
|Earnings date||21 Apr 2021 - 26 Apr 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||94.25|
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons.
Last week, you might have seen that Edwards Lifesciences Corporation ( NYSE:EW ) released its annual result to the...